
Hormone therapy supercharges tirzepatide, unleashing major weight loss after menopause
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight

Monday, June 30, 2025 NIH study could help to guide clinical recommendations for hormone

A pioneering research study published today in Cell Metabolism details how the hormone FGF21

Hormone levels fluctuate like the tides, ebbing and flowing according to carefully orchestrated cycles.